Look outside the ASX 20: Yarra Capital’s Dion Hershan on finding value in mid caps
Rask Australia
August 19, 2024
Yarra Capital’s Dion Hershan joins Owen Rask on The Australian
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Yarra Capital’s Dion Hershan joins Owen Rask on The Australian
The Wesfarmers Ltd (ASX:WES) share price has risen 29.8% since
The Resmed CDI (ASX:RMD) share price is up 34.3% since
The Wesfarmers Ltd (ASX:WES) share price has jumped 27.6% since
The Resmed CDI (ASX:RMD) share price has risen 30.6% since
The Wesfarmers Ltd (ASX:WES) share price has risen 23.5% since
The Resmed CDI (ASX:RMD) share price is up 28.6% since
The Wesfarmers Ltd (ASX:WES) share price has jumped 24.2% since
The Resmed CDI (ASX:RMD) share price has risen 27.8% since
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
By downloading, you agree to receive emails from us. You can unsubscribe anytime.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.